Microorganisms, cell cultures, and human endoparasites—including genetically modified organisms—that can cause infection, allergy, or toxicity. Subject to risk classification (Groups 1-4) and strict occupational safety, containment, and notification requirements.
Foresight tracks Biological Agents developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.
Not ready for a trial? Take the 3-minute readiness assessment
Current activity
233% above the prior 8-week baseline
3-month trend
Latest alerts below
Last updated
20 May 2026, 09:13
Source-backed regulatory and guidance signals tracked by Foresight, with the newest developments first.
US FDA Publishes Sugar Foods Recall of Kroger Homestyle Cheese Garlic Croutons for Possible Salmonella Contamination
Sugar Foods LLC has voluntarily recalled specific lots of Kroger Homestyle Cheese Garlic Croutons across multiple US states due to potential Salmonella contamination linked to a recalled milk-powder ingredient, with the recall announced on 15 May 2026 and published by FDA on 18 May 2026. The incident underscores the dependence of branded packaged foods on upstream ingredient safety, highlighting the need for strong supplier oversight, lot traceability, and rapid recall coordination between manufacturers, retailers, and regulators.
United StatesWHO Issues Infection Prevention and Control Guideline for Ebola and Marburg Diseases
WHO has issued a global infection prevention and control guideline for Ebola and Marburg diseases, published on 17 May 2026. The 238-page document sets expectations for multisectoral outbreak preparedness and community protection, guiding how health and emergency planners integrate IPC measures and service continuity into responses to high-consequence viral outbreaks.
GlobalUKHSA Publishes Guidance on Biological Principles for Control of MERS-CoV
UK Health Security Agency has issued new guidance on the biological principles and transmission of MERS-CoV to support control measures and HCID management pathways in England. This guidance clarifies expectations for isolation, PPE, and environmental decontamination for suspected and confirmed cases, strengthening occupational safety and outbreak preparedness for healthcare and related organisations.
United KingdomMississippi HAN Advisory on ICU Medical IV Tubing Contamination and Hantavirus/Andes Virus Guidance
Mississippi’s health department has issued a statewide HAN advisory on visible contamination in specified ICU Medical IV tubing products and updated its public guidance on Hantavirus and Andes virus in mid-May 2026. These actions prompt healthcare facilities to inspect and report affected tubing and to stay alert to evolving infectious disease guidance, reinforcing patient-safety and risk-management practices without creating new formal legal obligations.
United StatesWHO Issues Interim Guidance on Laboratory Testing for Andes Virus in Non-Endemic Areas
In May 2026, WHO issued interim global guidance for laboratories on testing for Andes virus (Orthohantavirus andesense) infection in non-endemic areas. The document is non-binding but will guide how health authorities and diagnostic services design or update Andes virus testing workflows, biosafety procedures, and outbreak preparedness plans.
GlobalGermany ZKBS 269th Meeting Issues New Risk-Group Classifications and MERS-CoV PPE Guidance
Germany’s Central Commission for Biological Safety has issued new risk-group assignments for specific microorganisms, updated its risk assessment for MERS-CoV under the Genetic Engineering Safety Ordinance framework, and adopted general guidance on bacteriophage and archaeal virus risks following its 269th meeting in May 2026. Companies and research institutions operating German gene technology facilities should review organism classifications, containment concepts, and PPE, including P3 respirator use for biosafety level 3 MERS-CoV work, to ensure their biosafety documentation and approvals remain aligned with the latest ZKBS recommendations.
GermanyFrance Issues Recall Over Listeria Monocytogenes in Cheese (RASFF 2026.4228)
France has issued a serious RASFF alert and national recall after company testing found very high levels of Listeria monocytogenes in cheese, far above listed safety criteria and involving supply-chain links between France, Spain and Portugal. This development heightens microbiological risk for chilled dairy products and underscores the need for operators in these markets to tighten Listeria controls, traceability and recall readiness.
European Union
France
Portugal
SpainJapan CAA Publishes New Consumer Accident, Food Poisoning and Recall Cases in Accident Information Databank (14 May 2026)
Japan’s Consumer Affairs Agency has added new consumer accident reports, food poisoning outbreaks and numerous food and vehicle recall cases to its Accident Information Databank under the Consumer Safety Act in mid-May 2026. While the notice does not introduce new general rules, it flags specific high-risk products and vehicles – especially CLASS I food recalls and lithium-ion-battery-related vehicle campaigns – that manufacturers, importers and retailers serving the Japanese market should track for safety, liability and brand-risk management.
JapanNetherlands Grants GMO Environmental Permit For Adenoviral Gene Therapy Trial At Leiden Academic Hospital
In May 2026 the Netherlands granted an environmental permit to Academisch Ziekenhuis Leiden for a clinical gene therapy trial using a replication-deficient adenoviral vector, following a public consultation with no objections. This authorisation imposes specific biosafety and environmental management obligations on the permit holder but does not create new sector-wide or product-market requirements, while signalling continued close oversight of GMO-based clinical research.
NetherlandsMissouri Division of Cannabis Regulation Recalls Sinse "Permanent Marker" 14 g Prepackaged Flower for Aspergillus Contamination
In May 2026, Missouri’s Division of Cannabis Regulation ordered a recall of a Sinse “Permanent Marker” 14 g prepackaged cannabis flower lot after it failed state testing for Aspergillus mold, although no adverse reactions had yet been reported. The action shows that Missouri’s routine sampling programme is actively triggering targeted cannabis recalls, so licensees and retailers need robust traceability to lot IDs, compliance with testing rules, and ready-to-activate recall and consumer communication processes.
United StatesOhio House Introduces Healthy Homes Program Act on Mold, Lead, Radon, and Carbon Monoxide
On 30 April 2026, Ohio lawmakers introduced the Healthy Homes Program Act (HB 841), which would add a new section 3701.68 to the state public health code and require the Director of Health to establish an information and awareness programme on household hazards from mold, lead, radon and carbon monoxide. This early-stage proposal primarily affects the Ohio Department of Health for now, but signals increased focus on indoor environmental exposures in housing that compliance and EHS teams may wish to monitor for potential downstream impacts on landlords, builders and home-related products.
United StatesFrance: Parliamentary Report on Bill Updating Military Programming Law (Stocks, OIVs and NRBC Powers)
France has tabled a defence bill updating the 2024–2030 Military Programming Law that would impose new strategic stock obligations on critical suppliers and operators while expanding emergency powers for NRBC and biotech medical countermeasures and streamlining environmental permitting for defence projects. If adopted, it would give the government broader tools to compel resilience across defence supply chains and vital operators and to develop, authorise, and rapidly deploy specialised countermeasures under defence-specific regimes, with knock-on implications for OIVs, logistics, and health-related manufacturers.
FranceNetherlands Issues GMO Environmental Permit IM 250019_001 to Prinses Máxima Centrum
The Netherlands has granted a GMO environmental permit to Prinses Máxima Centrum for ex vivo lentiviral modification of patient T-cells in a CNS cancer therapy trial, with documents available from early May 2026 and a six-week appeal window. This illustrates how the Dutch GMO environmental regime is being applied to advanced cell and gene therapies, signalling expectations for robust risk assessment, transparency, and public-law oversight in similar projects.
NetherlandsGreat Britain: Cardiff University Fined £280,000 Following HSE Prosecution Over Occupational Asthma
HSE has prosecuted Cardiff University after two laboratory employees developed disabling occupational asthma from long-term exposure to animal allergens, resulting in a £280,000 fine plus costs in April 2026. The case signals that universities and research institutions must rigorously apply COSHH-based controls and health surveillance for biological allergens or face significant enforcement, cost, and reputational risk.
United KingdomAustria (Salzburg) Amends Employee Protection Regulation To Apply 2025 OEL And Health Surveillance Ordinances
Salzburg has amended its Employee Protection Regulation 2021 to apply Austria’s 2025 occupational exposure limit and workplace health-surveillance ordinances, with the changes entering into force on 9 January 2026. Public-sector employers in Salzburg must now align risk assessments, exposure controls, and worker health monitoring with updated national and EU requirements for hazardous substances including lead, diisocyanates, asbestos, and biological agents, tightening compliance expectations for public workplaces.
AustriaUS CDC Seeks Comment On Maritime-Related Public Health Information Collection (PRA 30-Day Notice)
CDC has opened a 30-day comment period on a reinstated and consolidated maritime public health information collection (OMB 0920-1335) that underpins illness and death reporting from ships under federal quarantine authorities. Maritime operators and cruise lines face continued reporting and investigation burdens under 42 CFR parts 70 and 71 and may wish to review or comment on the forms ahead of the 14 May 2026 deadline to influence future administrative expectations.
United StatesEU Parliament ENVI/SANT Committees Consider Biotech Act Directive on GMMs and Organ Processing
EU lawmakers have begun detailed scrutiny of a Biotech Act directive that would modernise GMO rules for genetically modified micro-organisms and clarify regulation of organ processing before transplantation. This early committee debate signals future changes to risk assessment, authorisation duration, and oversight of low-risk GMMs and organ-processing technologies that biotech firms and transplant centres must track in their pipelines and compliance planning.
European UnionUkraine Drafts Amendments to Biosafety and Biological Protection Strategy Action Plan (CMU Order No. 573-r/2022)
Ukraine has published a draft Cabinet resolution to amend Order No. 573‑r/2022, which approves the national action plan for implementing the 2022‑2025 Biosafety and Biological Protection Strategy. If adopted, the revised plan will fine-tune government tasks and timelines on biosafety, signalling ongoing policy focus on biological risks and potential follow-on regulatory initiatives affecting laboratories, agriculture, and environmental management.
UkraineSTAMI Publishes Study on Bioaerosol Exposure in Norwegian Salmon Processing Workers
Norway’s occupational health institute STAMI has published new data showing that workers in salmon processing plants are still exposed to significant airborne protein levels in filleting and slaughtering areas, while endotoxin levels remain low and below some recommended limits. Although no new exposure limits are proposed, the findings highlight persistent bioaerosol exposure across facilities and are likely to inform future discussions on respiratory risk controls and occupational disease recognition in the Norwegian salmon industry.
NorwayCanada Adds Four Living Organisms To Domestic Substances List Under CEPA (SOR/2026-52)
Canada has added four living organisms, including a viral vector, human hematopoietic stem cells, and two therapeutic bacteriophages, to the Domestic Substances List under the Canadian Environmental Protection Act. This reclassification treats them as existing substances, removing New Substances Notification requirements for future manufacture or import and signalling continued expansion of Canada’s biotech regulatory baseline.
CanadaThese are just a few of the most recent Biological Agents alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.
Start free trialTopic context
Definition
Microorganisms, cell cultures, and human endoparasites—including genetically modified organisms—that can cause infection, allergy, or toxicity. Subject to risk classification (Groups 1-4) and strict occupational safety, containment, and notification requirements.
Industry relevance
Biological Agents developments can change product scope, supplier expectations, market access, reporting duties, and risk ownership. Foresight tracks the signals early so teams can respond before obligations become urgent.
Foresight tracking
Foresight monitors official sources, extracts structured regulatory intelligence, and maps alerts to a customer's products, substances, markets, and priorities so teams see the relevant signal with source evidence for review.
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at
